Literature DB >> 6705649

Basis for failure of cimetidine in patients with Zollinger-Ellison syndrome.

R T Jensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6705649     DOI： 10.1007/bf01318525

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  21 in total

1.  Malabsorption and jejunal ulceration due to gastric hypersecretion with pancreatic islet-cell hyperplasia.

Authors:  W H SUMMERSKILL
Journal:  Lancet       Date:  1959-01-17       Impact factor: 79.321

2.  The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome.

Authors:  C T Richardson; J H Walsh
Journal:  N Engl J Med       Date:  1976-01-15       Impact factor: 91.245

3.  The Zollinger-Ellison syndrome with steatorrhea. II. The mechanism of fat and vitamin B 12 malabsorption.

Authors:  S S Shimoda; D R Saunders; C E Rubin
Journal:  Gastroenterology       Date:  1968-12       Impact factor: 22.682

4.  Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome.

Authors:  J P Raufman; S M Collins; S J Pandol; L Y Korman; M J Collen; M J Cornelius; M K Feld; D M McCarthy; J D Gardner; R T Jensen
Journal:  Gastroenterology       Date:  1983-01       Impact factor: 22.682

Review 5.  Drug interactions with cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

Review 6.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

7.  Report on the United States experience with cimetidine in Zollinger-Ellision syndrome and other hypersecretory states.

Authors:  D M McCarthy
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

8.  Cimetidine in the treatment of Zollinger-Ellison syndrome.

Authors:  C W Deveney; S Stein; L W Way
Journal:  Am J Surg       Date:  1983-07       Impact factor: 2.565

9.  Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion.

Authors:  M J Collen; J M Howard; K E McArthur; J P Raufman; M J Cornelius; C A Ciarleglio; J D Gardner; R T Jensen
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

10.  Cimetidine plasma concentration-response relationships.

Authors:  R Gugler; G Fuchs; M Dieckmann; A A Somogyi
Journal:  Clin Pharmacol Ther       Date:  1981-06       Impact factor: 6.875
View more
  8 in total

Review 1.  Gastrinomas: Medical or Surgical Treatment.

Authors:  Jeffrey A Norton; Deshka S Foster; Tetsuhide Ito; Robert T Jensen
Journal:  Endocrinol Metab Clin North Am       Date:  2018-09       Impact factor: 4.741

2.  Duodenal ulcers which do not heal rapidly.

Authors:  K G Wormsley
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-27

Review 3.  Use of omeprazole in patients with Zollinger-Ellison syndrome.

Authors:  H Frucht; P N Maton; R T Jensen
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

4.  Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.

Authors:  R Vinayek; W F Hahne; A R Euler; J A Norton; R T Jensen
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

Review 5.  Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.

Authors:  Paola Tomassetti; Teresa Salomone; Marina Migliori; Davide Campana; Roberto Corinaldesi
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 6.  Current diagnosis and management of Zollinger-Ellison syndrome.

Authors:  D K Andersen
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

Review 7.  Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome.

Authors:  D C Metz; J R Pisegna; V A Fishbeyn; R V Benya; R T Jensen
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

8.  Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome.

Authors:  D C Metz; J R Pisegna; G L Ringham; K Feigenbaum; P D Koviack; P N Maton; J D Gardner; R T Jensen
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.